Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, and China.
Flawless balance sheet with proven track record.
Share Price & News
How has Quantum Health Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: QD4's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: QD4 exceeded the German Healthcare industry which returned 2.4% over the past year.
Return vs Market: QD4 exceeded the German Market which returned 0.1% over the past year.
Price Volatility Vs. Market
How volatile is Quantum Health Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Quantum Health Group undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: QD4 (€0.01) is trading above our estimate of fair value (€0)
Significantly Below Fair Value: QD4 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: QD4 is good value based on its PE Ratio (11.4x) compared to the Healthcare industry average (26.7x).
PE vs Market: QD4 is good value based on its PE Ratio (11.4x) compared to the German market (19.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate QD4's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: QD4 is good value based on its PB Ratio (1.4x) compared to the DE Healthcare industry average (1.4x).
How is Quantum Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Quantum Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Quantum Health Group is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Quantum Health Group competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Quantum Health Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QD4 has high quality earnings.
Growing Profit Margin: QD4's current net profit margins (7.2%) are higher than last year (4.9%).
Past Earnings Growth Analysis
Earnings Trend: QD4 has become profitable over the past 5 years, growing earnings by 52.3% per year.
Accelerating Growth: QD4's earnings growth over the past year (12%) is below its 5-year average (52.3% per year).
Earnings vs Industry: QD4 earnings growth over the past year (12%) exceeded the Healthcare industry 6.1%.
Return on Equity
High ROE: QD4's Return on Equity (11.5%) is considered low.
How is Quantum Health Group's financial position?
Financial Position Analysis
Short Term Liabilities: QD4's short term assets (A$32.2M) exceed its short term liabilities (A$28.7M).
Long Term Liabilities: QD4's short term assets (A$32.2M) exceed its long term liabilities (A$3.0M).
Debt to Equity History and Analysis
Debt Level: QD4's debt to equity ratio (35.7%) is considered satisfactory.
Reducing Debt: QD4's debt to equity ratio has reduced from 38.7% to 35.7% over the past 5 years.
Debt Coverage: QD4's debt is well covered by operating cash flow (35.2%).
Interest Coverage: QD4's interest payments on its debt are well covered by EBIT (7.7x coverage).
What is Quantum Health Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate QD4's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QD4's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if QD4's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QD4's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of QD4's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
John Walstab (56yo)
Mr. John Andrew Walstab has been Managing Director of Quantum Health Group Limited (formerly known as Quantum Energy Limited) since February 7, 2017 and serves as its Chief Executive Officer and served as ...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD0.00) is below average for companies of similar size in the German market ($USD422.82K).
Compensation vs Earnings: John's compensation has increased by more than 20% in the past year.
|CEO, MD & Executive Director||3.17yrs||AU$396.72k||45.54% A$12.0m|
|Chairman||16.83yrs||no data||0.077% A$20.1k|
|Independent Non-Executive Director||2.58yrs||no data||no data|
Experienced Board: QD4's board of directors are seasoned and experienced ( 16.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.
Quantum Health Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Quantum Health Group Limited
- Ticker: QD4
- Exchange: DB
- Founded: 1975
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: AU$44.004m
- Listing Market Cap: AU$26.279m
- Shares outstanding: 1.13b
- Website: https://www.qhealthcare.com.au
Number of Employees
- Quantum Health Group Limited
- 56 Bourke Road
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|QTM||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|QD4||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jan 1992|
|QTM||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, South Korea, Vietnam, New Zealand, and China. The company distributes medical products in the field of radiology, nuclear medicine, oncology, and women’s health. It also manufactures and distributes water sterilization and hot water systems for use in hospitals and aged care facilities, as well as offers installation services of related systems. The company was formerly known as Quantum Energy Limited. Quantum Health Group Limited was founded in 1975 and is headquartered in Sydney, Australia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/31 21:50|
|End of Day Share Price||2020/05/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.